Abstract:The aim of this study was to explore the expression of integrin-β1 in different stages of hepatic fibrosis and intervention of resveratrol as well as the way by which integrin-β1 promoted hepatic fibrosis. Hepatic fibrosis models of male Sprague Dawley (SD) rats were created and intragastric administration of resveratrol was given in low (40 mg/kg), middle (120 mg/kg) and high (200 mg/kg) dose groups. The expression of integrin-β1, transforming growth factor-β (TGF-β) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in different stages of hepatic fibrosis was detected by using RT-PCR. The expression of hexadecenoic acid (HA) and precollagen III (pc III) was assayed by radioimmunoassay. The expression of integrin-β1, TGF-β and TIMP-1 was determined in each group. Liver function and pathological sections of each group in different stages of hepatic fibrosis was tested to judge the therapeutic efficacy of resveratrol at different doses. The expression of integrin-β1 in normal control group was low and steady and was not increased with the development of hepatic fibrosis, but it was increased in other groups. The expression levels of integrin-β1 in the model control group (0.878 ± 0.03, P<0.01) and low dose group (0.855 ± 0.04, P<0.01) were higher than other groups, but there was no difference between model control group and low dose group (P>0.05). The expression levels of integrin-β1 and TGF-β in middle dose group and high dose group were higher than other groups (P<0.01). The expression levels of integrin-β1 and TGF-β in model control group and low dose group were lower than the normal control group (P<0.01). The expression levels of TIMP-1 in the model control and low dose groups were higher than the other groups (P<0.01). The expression levels of TIMP-1 in the middle dose group and the high dose group were lower than the normal control group (P<0.01). The expression of integrin-β1 existed in all stages of hepatic fibrosis of SD rats, and it was increased with the development of hepatic fibrosis. The expression of TGF-β and TIMP-1 was consistent with that of integrin-β1 in different stages of hepatic fibrosis. Resveratrol could improve the degree of hepatic fibrosis of SD rats and decrease the expression of integrin-β1 markedly at a dose of 120 mg/kg.

Resveratrol Regulates Activated Hepatic Stellate Cells by Modulating NF‐κB and the PI3K/Akt Signaling Pathway

Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway

Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and Inflammation

The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells

Expression of Integrin in Hepatic Fibrosis and Intervention of Resveratrol

Luteolin-7-diglucuronide, a novel PTP1B inhibitor, ameliorates hepatic stellate cell activation and liver fibrosis in mice

Resveratrol Suppresses the Myofibroblastic Phenotype and Fibrosis Formation in Kidneys Via Proliferation‐related Signalling Pathways

Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings

Quercetin Attenuates the Activation of Hepatic Stellate Cells and Liver Fibrosis in Mice Through Modulation of HMGB1-TLR2/4-NF-κB Signaling Pathways.

Resveratrol treatment ameliorates hepatic damage via the TGF-β/SMAD signaling pathway in a phenobarbital/CCl4-induced hepatic fibrosis model

Pterostilbene Exerts Cytotoxicity on Activated Hepatic Stellate Cells by Inhibiting Excessive Proliferation Through the Crosstalk of Sirt1 and STAT3 Pathways.

Antifibrotic Effects of Luteolin on Hepatic Stellate Cells and Liver Fibrosis by Targeting AKT/mTOR/p70S6K and TGFβ/Smad Signalling Pathways

Effects of Resveratrol on Chronic Liver Fibrosis in Rats

Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats

NLRC5 Regulates TGF-β1-induced Proliferation and Activation of Hepatic Stellate Cells During Hepatic Fibrosis.

Effect of the regulation of retinoid X receptor-α gene expression on rat hepatic fibrosis.

PPAR Gamma Inhibits Growth of Rat Hepatic Stellate Cells and TGF Beta-Induced Connective Tissue Growth Factor Expression

Hepatic stellate cells as key target in liver fibrosis

Activated NK cells kill hepatic stellate cells via p38/PI3K signaling in a TRAIL‐involved degranulation manner

STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.

Inhibitory Effects of Quercetin on the Progression of Liver Fibrosis Through the Regulation of NF-кB/IкBα, P38 MAPK, and Bcl-2/Bax Signaling